RMG Wealth Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
RMG Wealth Management's KLDO Position: Q1 2026 in Review
RMG Wealth Management opened a new position in Kaleido Biosciences, Inc. Common Stock (KLDO) in Q1 2026: 70 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #664 among its holdings. This is a return to the name: RMG Wealth Management previously reported a position in KLDO as recently as Q3 2025.
RMG Wealth Management first reported a position in KLDO in Q2 2025 and has held it in 3 quarters since. 3 funds tracked by Wall St. Rank hold KLDO as of Q1 2026.
- RMG Wealth Management held 70 shares of Kaleido Biosciences, Inc. Common Stock worth $0 as of Q1 2026.
- Kaleido Biosciences, Inc. Common Stock was a new RMG Wealth Management position in Q1 2026.
- Kaleido Biosciences, Inc. Common Stock made up ﹤0.01% of RMG Wealth Management's portfolio in Q1 2026, its #664 holding.
- RMG Wealth Management first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2025 and has held it in 3 quarters since.
- 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2026.
Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.